ADAR1 Capital Management »

Boundless Bio shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Boundless Bio (BOLD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.9M 2.0M 2.50

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Boundless Bio

FMR
Arch Venture Corp
Tang Capital Management
ADAR1 Capital Management
Sectoral Asset Management
Vanguard Capital Management
Wellington Management Company
Renaissance Technologies
Alyeska Investment Group
Affinity Asset Advisors
Rbf Capital
Ensign Peak Advisors
Sio Capital Management
Stonepine Capital Management
Citadel Advisors

View all funds holding Boundless Bio